-
1
-
-
0026567280
-
Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine
-
1 Howson, C.P. and Fineberg, H.V. Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine. JAMA 1992, 267, 392.
-
(1992)
JAMA
, vol.267
, pp. 392
-
-
Howson, C.P.1
Fineberg, H.V.2
-
2
-
-
0026322902
-
Frequent symptoms after DTPP vaccinations
-
2 Verschoor, P.L., Wilschut, J.T., de Jonge, G.A. and Kostense, P.J. Frequent symptoms after DTPP vaccinations. Arch. Dis. Child 1991, 66, 1408.
-
(1991)
Arch. Dis. Child
, vol.66
, pp. 1408
-
-
Verschoor, P.L.1
Wilschut, J.T.2
De Jonge, G.A.3
Kostense, P.J.4
-
3
-
-
0026585849
-
Development and clinical testing of an acellular pertussis vaccine containing genetically detoxified pertussis toxin
-
3 Rappuoli, R., Pizza, M. and De Magistris, MT. et al. Development and clinical testing of an acellular pertussis vaccine containing genetically detoxified pertussis toxin. Immunobiology 1992, 184, 230.
-
(1992)
Immunobiology
, vol.184
, pp. 230
-
-
Rappuoli, R.1
Pizza, M.2
De Magistris, M.T.3
-
4
-
-
0021350927
-
Development of a pertussis component vaccine in Japan
-
4 Sato, Y., Kimura, M. and Fukumi, H. Development of a pertussis component vaccine in Japan. Lancet 1984, 1, 122.
-
(1984)
Lancet
, vol.1
, pp. 122
-
-
Sato, Y.1
Kimura, M.2
Fukumi, H.3
-
5
-
-
84920205236
-
Placebo-controlled trial of two acellular pertussis vaccines in Sweden, protective efficacy and adverse events
-
5 Ad Hoc Group for the Study of Pertussis Vaccines. Placebo-controlled trial of two acellular pertussis vaccines in Sweden, protective efficacy and adverse events. Lancet 1988, 1, 955.
-
(1988)
Lancet
, vol.1
, pp. 955
-
-
-
6
-
-
0029866121
-
Randomized controlled trial of acellular diphtheria, pertussis and tetanus vaccines in southern Ghana
-
6 Afari, E.A., Kamiya, Y. and Nkrumah, F.K. et al. Randomized controlled trial of acellular diphtheria, pertussis and tetanus vaccines in southern Ghana. Ann. Trop. Paediatr. 1996, 16, 39.
-
(1996)
Ann. Trop. Paediatr.
, vol.16
, pp. 39
-
-
Afari, E.A.1
Kamiya, Y.2
Nkrumah, F.K.3
-
7
-
-
9044253706
-
Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States
-
7 Bernstein, H.H., Rothstein, E.P. and Pichichero, M.E. et al. Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States. Vaccine 1995, 13, 1631.
-
(1995)
Vaccine
, vol.13
, pp. 1631
-
-
Bernstein, H.H.1
Rothstein, E.P.2
Pichichero, M.E.3
-
8
-
-
0029156756
-
Comparison of 13 acellular pertussis vaccines: Adverse reactions
-
8 Decker, M.D., Edwards, K.M. and Steinhoff, M.C. et al. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics 1995, 96, 557.
-
(1995)
Pediatrics
, vol.96
, pp. 557
-
-
Decker, M.D.1
Edwards, K.M.2
Steinhoff, M.C.3
-
9
-
-
13344286322
-
A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis
-
Progetto Pertosse Working Group
-
9 Greco, D., Salmaso, S. and Mastrantonio, P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N. Engl. J. Med. 1996, 334, 341.
-
(1996)
N. Engl. J. Med.
, vol.334
, pp. 341
-
-
Greco, D.1
Salmaso, S.2
Mastrantonio, P.3
-
10
-
-
0030058665
-
A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine
-
10 Gustafsson, L., Hallander, H.O., Olin, P., Reizenstein, E. and Storsaeter, J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 1996, 334, 349.
-
(1996)
N. Engl. J. Med.
, vol.334
, pp. 349
-
-
Gustafsson, L.1
Hallander, H.O.2
Olin, P.3
Reizenstein, E.4
Storsaeter, J.5
-
11
-
-
0028232732
-
Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine
-
The Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine
-
11 Podda, A., De Luca, E.C. and Contu, B. et al. Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. The Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine. J. Pediatr. 1994, 124, 921.
-
(1994)
J. Pediatr.
, vol.124
, pp. 921
-
-
Podda, A.1
De Luca, E.C.2
Contu, B.3
-
12
-
-
0029874592
-
The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment
-
12 Rosenthal, S., Chen, R. and Hadler, S. The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment. Arch. Pediatr. Adolesc. Med. 1996, 150, 457.
-
(1996)
Arch. Pediatr. Adolesc. Med.
, vol.150
, pp. 457
-
-
Rosenthal, S.1
Chen, R.2
Hadler, S.3
-
13
-
-
0026702941
-
Immunogenicity and reactogenicity of Takeda acellular pertussis-component diphtheria-tetanus-pertussis vaccine in 2-and 3-month-old children in Japan
-
13 Kamiya, H., Nu, R., Matsuda, T., Yasuda, N., Christenson, P.D. and Cherry, J.D. Immunogenicity and reactogenicity of Takeda acellular pertussis-component diphtheria-tetanus-pertussis vaccine in 2-and 3-month-old children in Japan. Am. J. Dis. Child 1992, 146, 1141.
-
(1992)
Am. J. Dis. Child
, vol.146
, pp. 1141
-
-
Kamiya, H.1
Nii, R.2
Matsuda, T.3
Yasuda, N.4
Christenson, P.D.5
Cherry, J.D.6
-
14
-
-
0028021587
-
Whole-cell and acellular pertussis vaccines
-
14 Wintermeyer, S.M., Nahata, M.C. and Kyllonen, K.S. Whole-cell and acellular pertussis vaccines. Ann. Pharmacother. 1994, 28, 925.
-
(1994)
Ann. Pharmacother.
, vol.28
, pp. 925
-
-
Wintermeyer, S.M.1
Nahata, M.C.2
Kyllonen, K.S.3
-
15
-
-
0025009942
-
Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial
-
15 Storsaeter, J., Hallander, H., Farrington, C.P., Olin, P., Mollby, R. and Miller, E. Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial. Vaccine 1990, 8, 457.
-
(1990)
Vaccine
, vol.8
, pp. 457
-
-
Storsaeter, J.1
Hallander, H.2
Farrington, C.P.3
Olin, P.4
Mollby, R.5
Miller, E.6
-
16
-
-
0025945271
-
Pathophysiology of reactions associated with pertussis vaccine
-
16 Blumberg, D.A., Mink, C.M. and Lewis, K. et al. Pathophysiology of reactions associated with pertussis vaccine. Dev. Biol. Stand. 1991, 73, 289.
-
(1991)
Dev. Biol. Stand.
, vol.73
, pp. 289
-
-
Blumberg, D.A.1
Mink, C.M.2
Lewis, K.3
-
17
-
-
0021962740
-
Pharmacological evaluation of purified component and whole-cell pertussis vaccine in the cardiovascular system of rats
-
17 De Wildt, D.J., De Jong, Y., Nijkamp, F.P. and Kreeftenberg, J.G. Pharmacological evaluation of purified component and whole-cell pertussis vaccine in the cardiovascular system of rats. J. Pharmacol. Exp. Trier. 1985, 232, 541.
-
(1985)
J. Pharmacol. Exp. Ther.
, vol.232
, pp. 541
-
-
De Wildt, D.J.1
De Jong, Y.2
Nijkamp, F.P.3
Kreeftenberg, J.G.4
-
18
-
-
0020585370
-
Impaired autonomie responsiveness of the cardiovascular system of the rat induced by a heat-labile component of Bordetella pertussis vaccine
-
18 De Wildt, D.J., Kreeftenberg, H.G. and Nijkamp, F.P. Impaired autonomie responsiveness of the cardiovascular system of the rat induced by a heat-labile component of Bordetella pertussis vaccine. infect. Immun. 1983, 41, 476.
-
(1983)
Infect. Immun.
, vol.41
, pp. 476
-
-
De Wildt, D.J.1
Kreeftenberg, H.G.2
Nijkamp, F.P.3
-
19
-
-
0020369574
-
Severe impairment of cholinergic and adrenergic responsiveness in Bordetella pertussis vaccinated rats
-
19 De Wildt, D.J., Kreeftenberg, J.G. and Nijkamp, F.P. Severe impairment of cholinergic and adrenergic responsiveness in Bordetella pertussis vaccinated rats. Eur. J. Pharmacol. 1982, 86, 315.
-
(1982)
Eur. J. Pharmacol.
, vol.86
, pp. 315
-
-
De Wildt, D.J.1
Kreeftenberg, J.G.2
Nijkamp, F.P.3
-
20
-
-
0029087304
-
Association of reactions after consecutive acellular or whole-cell pertussis vaccine immunizations
-
20 Deloria, M.A., Blackwelder, W.C. and Decker, M.D. et al. Association of reactions after consecutive acellular or whole-cell pertussis vaccine immunizations. Pediatrics 1995, 96, 592.
-
(1995)
Pediatrics
, vol.96
, pp. 592
-
-
Deloria, M.A.1
Blackwelder, W.C.2
Decker, M.D.3
-
21
-
-
0026308788
-
Comparison of toxicities of acellular pertussis vaccine with whole cell pertussis vaccine in experimental animals
-
21 Sato, Y. and Sato, H. Comparison of toxicities of acellular pertussis vaccine with whole cell pertussis vaccine in experimental animals. Dev. Biol. Stand. 1991, 73, 251.
-
(1991)
Dev. Biol. Stand.
, vol.73
, pp. 251
-
-
Sato, Y.1
Sato, H.2
-
22
-
-
0022458548
-
Effect of pertussis toxin on the heart muscarinic-cholinergic receptors and their function
-
22 Boyer, J.L., Martinez Carcamo, M. and Monroy Sanchez, A. et al. Effect of pertussis toxin on the heart muscarinic-cholinergic receptors and their function. Life Sci. 1986, 39, 603.
-
(1986)
Life Sci.
, vol.39
, pp. 603
-
-
Boyer, J.L.1
Martinez Carcamo, M.2
Monroy Sanchez, A.3
-
23
-
-
0021022316
-
Pertussis toxin induces tachycardia and impairs the increase in blood pressure produced by alpha 2-adrenergic agonists
-
23 Boyer, J.L., Cardenas, C., Posadas, C. and Garcia Sainz, J.A. Pertussis toxin induces tachycardia and impairs the increase in blood pressure produced by alpha 2-adrenergic agonists. Life Sci. 1983, 33, 2627.
-
(1983)
Life Sci.
, vol.33
, pp. 2627
-
-
Boyer, J.L.1
Cardenas, C.2
Posadas, C.3
Garcia Sainz, J.A.4
-
24
-
-
0024592242
-
Pertussis toxin prevents adenosine receptor-and m-cholinoceptor-mediated sinus rate slowing and AV conduction block in the guinea-pig heart
-
24 Bohm, M., Schmitz, W., Scholz, H. and Wilken, A. Pertussis toxin prevents adenosine receptor-and m-cholinoceptor-mediated sinus rate slowing and AV conduction block in the guinea-pig heart. Naunyn Schmiedebergs Arch. Pharmacol. 1989, 339, 152.
-
(1989)
Naunyn Schmiedebergs Arch. Pharmacol.
, vol.339
, pp. 152
-
-
Bohm, M.1
Schmitz, W.2
Scholz, H.3
Wilken, A.4
-
25
-
-
0028934720
-
Effects of Bordetella pertussis toxin pretreatment on the antiarrhythmic action of ischaemic preconditioning in anaesthetized rats
-
25 Piacentini, L., Wainwright, C.L. and Parratt, J.R. Effects of Bordetella pertussis toxin pretreatment on the antiarrhythmic action of ischaemic preconditioning in anaesthetized rats. Br. J. Pharmacol. 1995, 114, 755.
-
(1995)
Br. J. Pharmacol.
, vol.114
, pp. 755
-
-
Piacentini, L.1
Wainwright, C.L.2
Parratt, J.R.3
-
26
-
-
0023110910
-
Pertussis toxin inhibits negative inotropic and negative chronotropic muscarinic cholinergic effects on the heart
-
26 Tucek, S., Dolezal, V., Folbergrova, J., Hynie, S., Kolar, F. and Ostadal, B. Pertussis toxin inhibits negative inotropic and negative chronotropic muscarinic cholinergic effects on the heart. Pflügers Arch. 1987, 408, 167.
-
(1987)
Pflügers Arch.
, vol.408
, pp. 167
-
-
Tucek, S.1
Dolezal, V.2
Folbergrova, J.3
Hynie, S.4
Kolar, F.5
Ostadal, B.6
-
27
-
-
0027752294
-
Modulation by pertussis toxin of salbutamol-and arecoline-induced effects in the isolated heart and aorta of the rat
-
27 Vleeming, W., Wemer, J., Riezebos, J., Van Amsterdam, J.G., De Wildt, D.J. and Porsius, A.J. Modulation by pertussis toxin of salbutamol-and arecoline-induced effects in the isolated heart and aorta of the rat. Eur. J. Pharmacol. 1993, 250, 415.
-
(1993)
Eur. J. Pharmacol.
, vol.250
, pp. 415
-
-
Vleeming, W.1
Wemer, J.2
Riezebos, J.3
Van Amsterdam, J.G.4
De Wildt, D.J.5
Porsius, A.J.6
-
28
-
-
0022106254
-
Attenuation of muscarinic cholinergic inhibition by islet-activating protein in the heart
-
28 Endoh, M., Maruyama, M. and Iijima, T. Attenuation of muscarinic cholinergic inhibition by islet-activating protein in the heart. Am. J. Physiol. 1985, 249, H309.
-
(1985)
Am. J. Physiol.
, vol.249
-
-
Endoh, M.1
Maruyama, M.2
Iijima, T.3
|